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Abstract
Background: Sub-Saharan Africa has been severely affected by the HIV and AIDS pandemic. Global efforts at 
improving care and treatment has included scaling up use of antiretroviral therapy (ART). In Tanzania, HIV care and 
treatment program, including the provision of free ART started in 2004 with a pilot program at Muhimbili National 
Hospital in Dar es Salaam. This study describes the socio-demographic and clinical features of patients enrolled at the 
care and treatment clinic at MNH, Dar es Salaam, Tanzania.
Methods: A cross-sectional study looking at baseline characteristics of patients enrolled at the HIV clinic at MNH 
between June 2004 - Dec 2005 compared to those enrolled between 2006 and September 2008.
Results: Of all enrolled patients, 2408 (58.5%) were used for analysis. More females than males were attending the 
clinic. Their baseline median CD4 cell count was low (136 cells/μl) with 65.7% having below 200 cells/μl. Females had 
higher CD4 cell counts (150 cells/μl) than males (109 cells/μl) p < 0.001). The most common presenting features were 
skin rash and/or itching (51.6%); progressive weight loss (32.7%) and fever (23.4). Patients enrolled earlier at the clinic 
(2004-5) were significantly more symptomatic and had significantly lower CD4 cell count (127 cells/μl) compared to 
CD4 of 167 cells/μl in those seen later (2006-8) (p < 0.001).
Conclusion: Patients enrolled to the MNH HIV clinic were predominantly females, and presented with advanced 
immune-deficiency. Improved access to HIV care and treatment services seems to be associated with patients' early 
presentation to the clinics in the course of HIV disease.
Background
HIV infection is a global pandemic. By the end of 2007 it
was estimated that about 33.2 million people were living
with HIV in the world. Among these, 22.5 million (68%)
are in sub-Saharan Africa [1].
Although the new UNAIDS and WHO reports show
leveling off of the HIV global prevalence as well as a
decrease in the number of new infections, HIV/AIDS is
still a problem that needs attention. It is thought that the
noted downward trend is in part a result of the impact of
HIV programmes [1]. The prevalence of HIV in Tanzania
during the year 2007 was 7% (11% in urban and 5% in
r u r a l  a r e a s )  [ 1 ] .  I n  r e s p o n s e  t o  t h e  g l o b a l  e f f o r t s  a t
improving care and treatment, the Tanzania government
in c olla bor a ti on wit h va rio us  pa rt ne rs  sta rt ed t he HIV
care and treatment in 2004 that included the provision of
free antiretroviral drugs [2]. Despite the generally known
fact that HIV-1 infection invariably leads to AIDS and
death, it is increasingly being reported that certain HIV-1
infected individuals remain healthy and free from AIDS
for as long as 15 yrs or more. A study conducted in Dar es
Salaam, Tanzania showed that with a definition of main-
taining a CD4+ cell slope ≤ -10 (loss of 10 or less cells per
year) 26% were long term slow progressors [3].
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The program started with a pilot phase conducted at
the Muhimbili National Hospital (MNH), a tertiary refer-
ral hospital in Dar es Salaam Tanzania. Since then care
and treatment expanded to cover the entire country.
Patients are enrolled and cared for in HIV clinics accord-
ing to the set National guidelines[4]. Easy access to care
and treatment, may have changed characteristics of HIV
infected persons seeking treatment in treatment centers.
This study aimed at describing changing social demo-
graphic and clinical characteristics of patients enrolled at
the Muhimbili National Hospital HIV clinic as the ART
program has developed.
Methods
The HIV care and treatment clinic (CTC) of MNH, in
Dar es Salaam, Tanzania was set up in June 2004. The
clinic was part of the National HIV care program that was
started countrywide to provide care and treatment
including provision of free ARV's. Patients' clinical infor-
mation at the clinic was monitored using a clinic visit
form. This information was and is still being regularly
entered into the computer. Data of patients enrolled
between June 2004 and September 2008 was used for
analysis. Eligible patients for this analysis were those aged
18 years and above. The clinic enrolled HIV positive
patients referred from voluntary testing and counseling
centers as well as hospitals in and around Dar es Salaam.
At enrollment a structured first-visit form was used to
collect patients' social demographic and clinical informa-
tion, physical findings and anthropometric measure-
ments. Opportunistic infections were diagnosed on the
basis of standard clinical definitions and individual labo-
ratory investigations. CD4 T-lymphocyte counts were
determined using FACS Count System (Becton Dickin-
son, San Jose, CA, USA). HIV disease severity was cate-
gorized using the WHO HIV disease staging whereby
stage I and II was categorized as mild disease, stage III as
moderate disease and stage IV was categorized as severe
disease. Immune suppression as indicated by CD4 T-cell
counts was divided into < 100 cells/μL, 100-200 cells/μL
and > 200 cells/μL.
Ethical Issues
The study received ethical clearance by the Muhimbili
University of Health and Allied Sciences (MUHAS) and
permission to conduct the study was granted by Muhim-
bili National Hospital (MNH).
Statistical analysis
Data were extracted from the hospital's Access data base
and analyzed using a statistical package for social sci-
ences (SPSS for windows, version 12.0). Means (Standard
deviations) and medians (Interquartile Ranges) were used
to describe the distributions of continuous variables. Per-
centages were used to describe categorical variables.
Comparisons of categorical data were performed with the
use of Pearson's chi-square test. For continuous data a
Student t-test was used to compare means.
Results
Between June 2004 and September 2008 the hospital
enrolled 4108 patients to its HIV clinic but only 2408
patients had complete documentation on the database
and were used for this analysis. Incomplete data for this
analysis included all individuals whose identification was
in doubt, i.e. names, age and sex were not indicated or
were actually in doubt. Also incomplete data included all
those who at baseline had no clinical information in their
records and had no baseline CD4 counts or did not have
clinical HIV staging. Individuals missing any one of these
important variables were excluded. Patients who were
excluded had similar social and demographic characteris-
tics to those finally analysed. (Table 1)
Table 2 summarizes the baseline characteristics of the
studied patients by recruitment period. The overall
median age at enrollment was 37 years, with males being
significantly older (p 0.003). Most patients (62.7%) were
below 40 years of age, with twice as many females as
males (ratio 2.2:1). Most patients (47.1%) were married,
and this was true among both male and female patients.
The mean body mass index (BMI) of the studied patients
was 22.8 ± 4.6 kg/m2.
At presentation to the clinic patients who were enrolled
earlier (2004-2005) 62.4% were WHO stages I and II,
26.2% and 11.3% were WHO stages III and IV respec-
tively. For patients who were enrolled later (2006-2008)
78.6% were WHO stages I&II, with 16.5% and 4.9% of
them being WHO stages III and IV respectively. These
findings were found to be statistically significant (p = <
0.001). Patients had an overall median CD4+ T lympho-
cyte count of 136 cells/μl (IQR 203). Two thirds (65.7%) of
all patients had CD4+ T lymphocyte counts below 200
cells/μl. Of those with CD4+ T lymphocyte counts below
200 cells/μl, more than half (61.5%) had CD4+ T lympho-
cyte counts below 100 cells. The median CD4+ T lym-
phocyte count for females (150 cells/μl) (IQR 212) was
significantly higher than that of males (109 cells/μl) (IQR
174), p < 0.001.
Patients enrolled during the first year of the program
(2004-5) had a significantly lower median CD4+ T lym-
phocyte count of 127 cells/μl (IQR 174) compared to that
of 167 cells/μl (IQR 256) among those enrolled in 2006-8,
(p < 0.001). Many, (26%) were ART experienced during
the first period, while almost none had received ART dur-
ing the latter period. (p = 0.01).
The common clinical presentations among patients at
the time of enrollment are shown in Table 2. The com-
m o n e s t  p r e s e n t i n g  c o m p l a i n t s  w e r e  s k i n  r a s h  a n d / o r
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(23.4%) and general body weakness (20.7%). Pruritic pur-
pura eruption, hair changes (described as silky hair) and
oral candidiasis were the commonest documented clini-
cal signs (Table 2). Weight loss, fever, abdominal pain
were the commonly reported symptoms among patients
enrolled in 2006-8 while numbness, lymphadenopathy
and Seborrhoeic dermatitis were significantly common
among patients enrolled in 2004-5.
In the past medical history patients reported to have
suffered from Herpes zoster (19.7%) and Tuberculosis
(20.6%) over the past 5 years. Those enrolled earlier
reported to have suffered from Herpes zoster (14.9%) and
Tuberculosis (16.5%) significantly higher than those who
were enrolled later, 4.8% and 4.1% respectively (p = <
0.001).
Common clinical symptoms and signs in relation to CD4 
counts
As expected, at enrolment patients whose CD4+ T lym-
phocyte counts were low were more symptomatic than
those with relatively higher counts. Furthermore, the fre-
quency of symptoms was noted to significantly decrease
with increasing CD4 counts. However, numbness, paras-
thesia, seborrhoeic dermatitis, Kaposi's sarcoma and
lymphadenopathy were not related to patients' level of
immunosuppression (Table 3).
Discussion
This study looked at the effect of easy access to antiretro-
viral therapy on the clinical characteristics of patients
attending the HIV clinic at Muhimbili National Hospital.
The clinical characteristics of patients seen during the
early stages of the program (2004-2005) were compared
with those seen in patients who presented later during
the program (2006-2008) when access to antiretroviral
therapy was wide spread in Tanzania and more so in the
city of Dar es Salaam where the study took place. Most
patients who reported to the clinic during the study
period (2004 to 2008) had relatively severe immunosup-
presion, this is indicated by their low median CD4 cell
count at presentation (136 cells/μl [IQR 203]). Although
patients who were enrolled to the clinic had severe
immunosuppression, those enrolled during the first years
of the program were found to be even more immuno-
compromised as compared to those enrolled later. This
was also true with clinical presentation, a lot more
patients were symptomatic at the beginning of the pro-
gram (2004-2005) compared to the period 2006-2008.
This difference in immune status and clinical characteris-
tics at the two periods can be explained by easy access of
antiretroviral drugs which could have increased aware-
ness and reduced stigma of the disease thereby leading to
early presentation to HIV clinics.
Before the National care and treatment programs
(2004) access to ARV's was very limited. Prior to the ART
care and treatment program, some patients who came to
the clinic were not ART naïve as those who could afford
to buy their own ARV's did so. However due to the high
cost, the experience at our clinic showed that there was
poor adherence to proper ART. With the start of the care
Table 1: Social demographic characteristics and HIV stage of the study population (n = 4108).
Baseline 
characteristics
Excluded
N = 1700 (41.4%)
Included
N = 2408** (58.6%)
p-value
Median Age (IQR) 906* 37 (16) 37 (12) 0.1173
Age groups 18-30 906* 183 (20.2) 458 (19.0) 0.8718
31-40 387 (42.7) 1054 (43.8)
41-50 224 (24.7) 604 (25.1%)
> 50 112 (12.3) 292 (12.1)
Sex Males 1342* 424 (31.6) 741 (30.8) 0.6019
Females 918 (68.4) 1667 (69.2)
Marital status Married 786* 358 (45.5) 1133 (47.1) 0.7583
Never married 284 (36.1) 842 (35.0)
Separated/
widowed
144 (18.3) 433 (18.0)
HIV stage I and II 426* 288 (67.6) 1642 (68.1) 0.7332
III 103 (24.2) 548 (22.8)
IV 35 (8.2) 218 (9.1)
*Number of individuals with available data in the excluded group
** Number of individuals with analysed data in the tableMugusi et al. BMC Public Health 2010, 10:291
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Table 2: Baseline Characteristics of enrolled patients at the HIV clinic at MNH 2004 to 2008 (N = 2408).
Characteristics All Patients
(N = 2408)
Enrolled  2004-5
(N = 1551)
Enrolled 2006-8
(N = 857)
P Value
Sex
Male 741(30.8) 489(31.5) 252(29.4)
Female 1667(69.2) 1062(68.5) 605(70.6) 0.280
Marital status
Married 1133(47.1) 654(42.2) 479(55.9)
Never married 842(35.0) 586(37.8) 256(29.9) < 0.001
Separated/
widowed
433(18.0) 311(20.1) 122(14.2)
Median age (IQR)* 37(12) 38(12) 37(12) < 0.003
Mean BMI, kg/m2 (SD) 22.8 ± 4.6 22.8 ± 4.6 22.9 ± 4.7 0.58
Median CD4 count, 
cells/μl (IQR)
136(203) 127(174) 167(256) < 0.001
WHO stages
Stage I&II 1642 (68.1) 968 (62.4) 674 (78.6) < 0.001
Stage III 548 (22.8) 407 (26.2) 141 (16.5)
Stage IV 218 (9.1) 176 (11.3) 42 (4.9)
Past medical history
Herpes Zoster 474(19.7) 358(14.9) 116(4.8) < 0.001
Tuberculosis 495(20.6) 397(16.5) 98(4.1) < 0.001
Type of HIV treatments at enrollment
No treatment 1942(80.6) 1089(70.2) 853(99.5) < 0.01
ARVs 401(16.7) 398(25.7) 3(0.4) < 0.01
Spiritual 19(0.8) 19(1.2) (0) < 0.01
Traditional 46(1.9) 45(2.9) 1(0.1) < 0.01
Symptoms
Progressive Wt loss 787(32.7) 471(30.4) 316(36.9) 0.001
Skin rash 623(25.9) 438(28.2) 185(21.6) < 0.001Mugusi et al. BMC Public Health 2010, 10:291
http://www.biomedcentral.com/1471-2458/10/291
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and treatment program, ARV's were provided free and
therefore a larger proportion of people who came to the
HIV clinic were ART naïve. Despite the free antiretroviral
drugs a number of patients still do acquire their drugs
from private pharmacies. Although drugs in these private
pharmacies are a lot cheaper than before 2004, they are
still expensive for most of the patients in Tanzania. A
number of patients having failed to buy drugs would then
come back to public HIV clinics. The absence and diffi-
culty of access to appropriate treatment early in the pro-
gram sometimes led to patients seeking alternative
treatments. Some patients in this study (2.7%) used other
forms of treatment for their illnesses including traditional
medicines and/or spiritual healing. The absence or inac-
cessibility to modern medicine increases the proportion
of patients using traditional or alternative medicines.
With increased access to ART, there was a reduction of
patients who had previously used traditional or alterna-
tive medicine as seen in patients who were enrolled in
2006-2008.
In this study males at presentation were more immuno-
compromised than females. The same finding was
reported in a study done in Kenyan HIV clinics [5],
though patients at MNH presented with even more
severe immunosupression. The reason why males pre-
sented with lower CD4 cell counts was not clear from this
study, however we can only speculate that men present
late to the clinic because of stigma which is probably
higher among men compared to women. The other rea-
son could be the difference in health seeking behavior of
m e n  c o m p a r e d  t o  t h a t  o f  w o m e n .  I t  w a s  f o u n d  t h a t
females formed the majority of enrolled patients at the
clinic. This finding is in agreement with other studies that
found more female enrollment to the clinics than men
[4]. This was true for both early and later in the program.
The results of this study indicate that young people
below the age of 40 years accounted for the majority of
clinic attendees. This is in keeping with earlier reported
national and global findings on the age group of patients
most affected with HIV [1,6,7].
It is apparent from this study that the time at presenta-
tion to the clinic for HIV care and treatment influences
the clinical spectrum of symptoms and signs seen at the
initial evaluation. Most patients find out their serostatus
after having suffered from a HIV related disease that
would have prompted a HIV test. VCT that is mainly per-
formed in healthy individuals may not necessarily lead to
a patient to seek medical care. In this study many patients
had one or more symptoms at baseline. Indeed the num-
ber of symptoms at enrollment was found to be linearly
Fever 564(23.4) 306 (19.7) 258(30.1) < 0.001
Productive cough 463(19.2) 288(18.6) 175(20.4) 0.27
Numbness 405(16.8) 269(17.3) 136(15.9) 0.354
Night sweat 358(14.9) 191 (12.3) 167 (19.5) < 0.001
Abdominal pain 312(13.0) 171(11) 141(16.5) < 0.001
Dry cough 246(10.2) 165(10.6) 81(9.5) 0.357
Anorexia 202(8.4) 142(9.2) 60(7) 0.178
Vomiting 188(7.8) 103(6.6) 85(9.9) 0.003
Nausea 182(7.6) 106(6.8) 76(8.9) 0.149
Genital lesions 155(6.4) 101(6.5) 54(6.3) 0.840
Diarrhoea 127(5.3) 29(1.9) 98(11.4) < 0.001
Odynophagia 93(3.9) 66(4.3) 27(3.2) 0.178
*IQR is Inter quartile range
Table 2: Baseline Characteristics of enrolled patients at the HIV clinic at MNH 2004 to 2008 (N = 2408). (Continued)Mugusi et al. BMC Public Health 2010, 10:291
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inversely related to the level of CD4+ T lymphocyte
counts. Similar findings have been reported from other
studies as well [4,6].
About one fifth of patients reported to have suffered
from tuberculosis or herpes zoster over the past 5 years
prior to enrollment; this finding is similar to what has
been found from other studies in Africa [4,8,9]. The his-
tory of having suffered from tuberculosis or herpes zoster
was reported more frequently in those enrolled early in
the program; this may be an indication of patients being
more symptomatic among those who presented early in
the program as compared to those who presented later.
Most opportunistic infections reflect the available patho-
gens in the environment. Tuberculosis is reported to be
the most common infectious disease from a single patho-
gen and it is highly prevalent in sub Sahara Africa and
hence its frequent finding in HIV infected patients. The
fact that T uberculosis occurs even in patients with rela-
tively good immune status will frequently be reported in
the patients past medical history [10-12]. This could
mean that easy access to ART makes patients come for-
ward early in the HIV disease progression before they
develop common opportunistic infections like tuberculo-
sis and herpes zoster. Of note also is the fact that derma-
tological disorders were a very common presentation in
patients in keeping with earlier reported findings[13,14].
Increased awareness of dermatological symptoms and
signs among health care workers for their presence
should provide an opportunity for offering VCT services.
Despite the improved access to ART and improved
clinical characteristics of patients attending ART clinics
the pattern of clinical presentation has not changed much
with time because still patients present late with severe
immunosuppression to the HIV clinics. There is there-
fore a need to improve awareness in the population
regarding the availability of care and treatment services,
improve HIV counseling and testing so that HIV infected
individuals can be identified early in disease progression.
This will enhance the appropriate accessibility to preven-
tive and curative services.
We do acknowledge the limitations associated with this
retrospective study that did not look at other variables
including psycho-social variables that would be associ-
ated with access to ARV's. A proper prospective study
would provide better information.
The noted limitation with data completeness in some
cases has been addressed by ascertaining that the group
with complete data was similar sociodemographically
with the group that had incomplete data.
Table 3: Common Clinical Symptoms and Signs by CD4 T-cell Counts among HIV-infected Patients (N = 2408).
Clinical features CD4 T-cell Counts
< 100 (n = 974) 100-200 (n = 609) > 200 (n = 825) P-value
N%N%N%
Wt Loss 418 42.9 170 27.9 199 24.1 < 0.001
Skin itching 307 31.5 157 25.8 156 18.9 < 0.001
Fever 288 29.6 121 19.9 155 18.8 < 0.001
General body weakness 273 28.0 111 18.2 114 13.8 < 0.001
Productive cough 251 25.8 90 14.8 122 14.8 < 0.001
Sweat 202 20.7 77 12.6 79 9.6 < 0.001
Numbness 185 19.0 104 17.1 116 14.1 0.02
Nausea/Vomiting 108 11.1 35 5.7 39 4.7 < 0.001
Dry cough 115 11.8 69 11.3 62 7.5 0.006
Paraesthesia 99 10.2 60 9.9 60 7.3 0.079
Diarrhea 76 7.8 23 3.8 20 3.4 < 0.001
D y s p h a g i a 6 87 . 01 72 . 83 54 . 2 < 0.001
Hair changes 184 18.9 62 10.2 39 4.7 < 0.001
Oral Candidiasis 165 16.9 42 6.9 42 5.1 < 0.001
Pallor 114 11.7 42 6.9 35 3.2 < 0.001
Chest Crackles 54 5.5 17 2.8 19 2.3 < 0.001
Seborrheic dermatitis 52 5.3 27 4.4 18 2.2 0.003
Angular cheilitis 45 4.6 17 2.8 14 1.7 < 0.001
Kaposi's sarcoma 40 4.1 12 2.0 20 2.4 0.026Mugusi et al. BMC Public Health 2010, 10:291
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Importantly, in our opinion this is the first paper to
show that easy access to antiretroviral drugs is associated
with improved clinical and immunological characteristics
of patients enrolled in HIV clinics.
Conclusion
Patients enrolled to the MNH HIV clinic were predomi-
nantly females, and presented with advanced immune-
deficiency. Improved access to HIV care and treatment
services seems to be associated with patients' early pre-
sentation to the clinics in the course of HIV disease. More
efforts need to be put in place to educate the public on
the need for regular HIV testing so that the problem is
caught earlier, allowing for subsequent appropriate acces-
sibility to preventive and curative services.
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